Us Bancorp \De\ Burning Rock Biotech LTD Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$2.39 - $3.96 $1,873 - $3,104	-784 Reduced 49.75%	792 $2,000
Q2 2022 Aug 01, 2022	SELL	$1.75 - $10.44 $23,854 - $142,307	-13,631 Reduced 89.64%	1,576 $5,000
Q1 2022 May 11, 2022	BUY	$6.7 - $10.23 $9,292 - $14,189	1,387 Added 10.04%	15,207 $142,000
Q4 2021 Feb 11, 2022	BUY	$9.43 - $17.14 $23,688 - $43,055	2,512 Added 22.21%	13,820 $132,000
Q3 2021 Nov 10, 2021	BUY	$17.37 - $27.92 $196,419 - $315,719	11,308 New	11,308 $202,000

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $705M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.